nivolumab,ipilimumab
bms
['biomarker']
no words to describe this advantage for patients and the power of biomarker-driven trials. super proud! #esmo22 
breast cancer immunotherapy investigator, mother, medical oncologist, PI and associate prof at NKI, happy in Amsterdam